• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

干细胞疗法治疗人类不孕:优势与挑战。

Stem Cell Therapies for Human Infertility: Advantages and Challenges.

机构信息

Department of Reproductive Medicine, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.

New England Fertility Institute, Stamford, CT, USA.

出版信息

Cell Transplant. 2022 Jan-Dec;31:9636897221083252. doi: 10.1177/09636897221083252.

DOI:10.1177/09636897221083252
PMID:35348026
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8969497/
Abstract

Physical and mental health and hormonal imbalance are associated with the problems related to infertility and reproductive disorders. The rate of infertility has increased globally over the years, due to various reasons. Given the psychosocial implications of infertility and its effects on the life of the affected people, there has been an increased focus on its treatment over the last several years. Assisted reproductive technology can only solve about 50% of the cases. Moreover, it contains significant risks and does not solve the fundamental problem of infertility. As pluripotent stem cells have the potential to differentiate into almost any type of cell, they have been widely regarded as a promising option in the development of stem cell-based fertility treatments, which could even correct genetic diseases in offspring. These advancements in reproductive biotechnology present both challenges and possibilities for solving infertility problems caused by various unexplainable factors. This review briefly presents the different types of infertility disorders and the potential applications of stem cells in the treatment of these reproductive diseases.

摘要

身心健康和激素失衡与不孕和生殖障碍相关问题有关。由于各种原因,近年来全球不孕率不断上升。鉴于不孕的心理社会影响及其对受影响者生活的影响,过去几年人们越来越关注其治疗方法。辅助生殖技术只能解决大约 50%的病例。此外,它还存在重大风险,并且不能解决不孕的根本问题。由于多能干细胞具有分化为几乎任何类型细胞的潜力,因此它们被广泛认为是基于干细胞的生育治疗发展的有前途的选择,甚至可以纠正后代的遗传疾病。生殖生物技术的这些进步为解决由各种不明原因因素引起的不孕问题带来了挑战和可能性。本文简要介绍了不同类型的不孕障碍和干细胞在治疗这些生殖疾病中的潜在应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af9c/8969497/90f6137b9baf/10.1177_09636897221083252-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af9c/8969497/17017c9b4151/10.1177_09636897221083252-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af9c/8969497/19477b6ab8dc/10.1177_09636897221083252-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af9c/8969497/90f6137b9baf/10.1177_09636897221083252-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af9c/8969497/17017c9b4151/10.1177_09636897221083252-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af9c/8969497/19477b6ab8dc/10.1177_09636897221083252-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af9c/8969497/90f6137b9baf/10.1177_09636897221083252-fig3.jpg

相似文献

1
Stem Cell Therapies for Human Infertility: Advantages and Challenges.干细胞疗法治疗人类不孕:优势与挑战。
Cell Transplant. 2022 Jan-Dec;31:9636897221083252. doi: 10.1177/09636897221083252.
2
Autologous Human Mesenchymal Stem Cell-Based Therapy in Infertility: New Strategies and Future Perspectives.基于自体人间充质干细胞的不孕症治疗:新策略与未来展望。
Biology (Basel). 2023 Jan 10;12(1):108. doi: 10.3390/biology12010108.
3
In Vitro Gamete Differentiation from Pluripotent Stem Cells as a Promising Therapy for Infertility.从多能干细胞进行体外配子分化作为一种有前景的不孕症治疗方法。
Stem Cells Dev. 2016 Apr 1;25(7):509-21. doi: 10.1089/scd.2015.0230.
4
Germ Cell Derivation from Pluripotent Stem Cells for Understanding In Vitro Gametogenesis.多能干细胞来源生殖细胞用于体外配子发生研究。
Cells. 2021 Jul 26;10(8):1889. doi: 10.3390/cells10081889.
5
Anxiety and depression in women undergoing infertility treatment.接受不孕症治疗的女性的焦虑和抑郁。
Ginekol Pol. 2017;88(2):109-112. doi: 10.5603/GP.a2017.0019.
6
Effectiveness of a mixed lifestyle program in couples undergoing assisted reproductive technology: a study protocol.辅助生殖技术治疗中夫妇混合生活方式方案的有效性:研究方案。
Reprod Health. 2023 Aug 1;20(1):112. doi: 10.1186/s12978-023-01652-6.
7
Comparison of three infertility-specific measures in men and women going through assisted reproductive technology treatment.比较三种在接受辅助生殖技术治疗的男性和女性中特定于不孕的措施。
J Health Psychol. 2019 May;24(6):738-749. doi: 10.1177/1359105316678669. Epub 2016 Nov 22.
8
Infertility and assisted reproduction in Denmark. Epidemiology and psychosocial consequences.丹麦的不孕症与辅助生殖。流行病学及心理社会后果。
Dan Med Bull. 2006 Nov;53(4):390-417.
9
ESHRE guideline: routine psychosocial care in infertility and medically assisted reproduction-a guide for fertility staff.欧洲人类生殖与胚胎学会指南:不孕不育及医学辅助生殖中的常规心理社会护理——生育工作人员指南
Hum Reprod. 2015 Nov;30(11):2476-85. doi: 10.1093/humrep/dev177. Epub 2015 Sep 7.
10
Application of Stem Cell Therapy for Infertility.干细胞治疗在不孕不育中的应用。
Cells. 2021 Jun 28;10(7):1613. doi: 10.3390/cells10071613.

引用本文的文献

1
The future of embryo engineering and fertility research in interdisciplinary collaboration.胚胎工程与生殖研究在跨学科合作中的未来。
Front Cell Dev Biol. 2025 Aug 29;13:1619050. doi: 10.3389/fcell.2025.1619050. eCollection 2025.
2
Effect of chitosan nanoparticles loaded with platelet lysate on in vitro fertilization and early embryo development in a mouse premature ovarian failure model.负载血小板裂解物的壳聚糖纳米颗粒对小鼠卵巢早衰模型体外受精和早期胚胎发育的影响
Iran J Basic Med Sci. 2025;28(7):937-945. doi: 10.22038/ijbms.2025.84330.18249.
3
Assisted Reproductive Technology: A Ray of Hope for Infertility.

本文引用的文献

1
Metabolic syndrome and the risk of cardiovascular complications in young patients with different phenotypes of polycystic ovary syndrome.代谢综合征与不同表型多囊卵巢综合征年轻患者心血管并发症风险的关系。
Endocrine. 2021 May;72(2):400-410. doi: 10.1007/s12020-020-02596-8. Epub 2021 Jan 13.
2
Genetic mutations contributing to non-obstructive azoospermia.导致非梗阻性无精子症的基因突变。
Best Pract Res Clin Endocrinol Metab. 2020 Dec;34(6):101479. doi: 10.1016/j.beem.2020.101479. Epub 2020 Dec 15.
3
lncRNA is involved in premature ovarian insufficiency by regulating p27 translation in GCs via competitive binding to PTBP1.
辅助生殖技术:不孕症患者的一线希望。
ACS Omega. 2025 May 23;10(22):22347-22365. doi: 10.1021/acsomega.5c01643. eCollection 2025 Jun 10.
4
H3K18 lactylation-mediated Ythdf2 activation restrains mouse female germline stem cell proliferation via promoting Ets1 mRNA degradation.H3K18乳酸化介导的Ythdf2激活通过促进Ets1 mRNA降解来抑制小鼠雌性生殖系干细胞增殖。
Clin Epigenetics. 2025 May 27;17(1):84. doi: 10.1186/s13148-025-01890-4.
5
Turner syndrome: the promise of fertility via stem cell technology.特纳综合征:通过干细胞技术实现生育的前景。
Hormones (Athens). 2025 Apr 2. doi: 10.1007/s42000-025-00647-1.
6
Advancing Cell Transplantation Research with Integrity and Rigor.以诚信和严谨推进细胞移植研究。
Cell Transplant. 2024 Jan-Dec;33:9636897241309996. doi: 10.1177/09636897241309996.
7
Mesenchymal stem cells and mesenchymal stem cell-derived exosomes: attractive therapeutic approaches for female reproductive dysfunction.间充质干细胞及其衍生的外泌体:治疗女性生殖功能障碍的有吸引力的治疗方法。
Mol Biol Rep. 2024 Nov 22;52(1):10. doi: 10.1007/s11033-024-10106-6.
8
Catalyzing IVF outcome prediction: exploring advanced machine learning paradigms for enhanced success rate prognostication.催化体外受精结果预测:探索先进的机器学习范式以提高成功率预测
Front Artif Intell. 2024 Nov 5;7:1392611. doi: 10.3389/frai.2024.1392611. eCollection 2024.
9
Revolutionizing medicine: recent developments and future prospects in stem-cell therapy.医学革命:干细胞治疗的最新进展与未来前景
Int J Surg. 2024 Dec 1;110(12):8002-8024. doi: 10.1097/JS9.0000000000002109.
10
Advances in Mesenchymal Stem Cell Research Applications for Female Infertility-Mechanisms, Efficacy Parameters, Challenges and Future Roadmap.间充质干细胞研究在女性不孕症中的应用进展——作用机制、疗效参数、挑战及未来路线图
Galen Med J. 2024 Oct 8;13:e3632. doi: 10.31661/gmj.v13i.3632. eCollection 2024.
长链非编码RNA通过与多聚嘧啶结合蛋白1竞争性结合来调控颗粒细胞中p27的翻译,从而参与卵巢早衰。
Mol Ther Nucleic Acids. 2020 Nov 4;23:132-141. doi: 10.1016/j.omtn.2020.10.041. eCollection 2021 Mar 5.
4
The dynamics and regulation of microfilament during spermatogenesis.精子发生过程中微丝的动态变化和调控。
Gene. 2020 Jun 20;744:144635. doi: 10.1016/j.gene.2020.144635. Epub 2020 Mar 31.
5
Etiology and management of recurrent implantation failure: A focus on intra-uterine PBMC-therapy for RIF.复发性着床失败的病因与治疗:以内膜间单个核细胞疗法治疗 RIF 为重点。
J Reprod Immunol. 2020 Jun;139:103121. doi: 10.1016/j.jri.2020.103121. Epub 2020 Mar 18.
6
Small extracellular vesicles derived from embryonic stem cells restore ovarian function of premature ovarian failure through PI3K/AKT signaling pathway.来源于胚胎干细胞的小细胞外囊泡通过 PI3K/AKT 信号通路恢复卵巢早衰的卵巢功能。
Stem Cell Res Ther. 2020 Jan 3;11(1):3. doi: 10.1186/s13287-019-1508-2.
7
Sonic Hedgehog, a Novel Endogenous Damage Signal, Activates Multiple Beneficial Functions of Human Endometrial Stem Cells. Sonic Hedgehog,一种新型内源性损伤信号,激活了人子宫内膜干细胞的多种有益功能。
Mol Ther. 2020 Feb 5;28(2):452-465. doi: 10.1016/j.ymthe.2019.11.024. Epub 2019 Dec 6.
8
Metabolic and transcriptional changes in seminal plasma of asthenozoospermia patients.弱精子症患者精浆中的代谢和转录变化
Biomed Chromatogr. 2020 Mar;34(3):e4769. doi: 10.1002/bmc.4769. Epub 2020 Jan 13.
9
miR-644-5p carried by bone mesenchymal stem cell-derived exosomes targets regulation of p53 to inhibit ovarian granulosa cell apoptosis.骨间充质干细胞来源的外泌体携带的 miR-644-5p 通过靶向调节 p53 抑制卵巢颗粒细胞凋亡。
Stem Cell Res Ther. 2019 Nov 29;10(1):360. doi: 10.1186/s13287-019-1442-3.
10
Mesenchymal Stem Cells Alleviate DHEA-Induced Polycystic Ovary Syndrome (PCOS) by Inhibiting Inflammation in Mice.间充质干细胞通过抑制小鼠炎症来缓解脱氢表雄酮诱导的多囊卵巢综合征(PCOS)
Stem Cells Int. 2019 Sep 12;2019:9782373. doi: 10.1155/2019/9782373. eCollection 2019.